- t2cure’s cell therapy is available through cooperating clinical centres
- t2cure cooperates with experienced partners in research and in the industry.
- t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
- t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.
Advisory Board
Prof. Dr. Andreas M. Zeiher (Founder)
Dr. Zeiher is board-certified in internal medicine and cardiology and has served on the faculties of Albert-Ludwigs-University of Freiburg from 1990 – 1995 as director of interventional cardiology. Since 1995, Dr. Zeiher is the Chairman of Medicine in the Department of Cardiology / Nephrology at the J. W. Goethe-University of Frankfurt.
Dr. Zeiher is the recipient of numerous awards, honors and grants and has published more than 200 articles and reviews. He is a fellow of the European Society of Cardiology. Dr. Zeiher is past-chairman of the Working Group on Interventional Cardiology of the European Society of Cardiology. He served on the editorial boards of several journals, including Circulation, Circulation Research, European Heart Journal and others.
His research interests include basic and clinical aspects of endothelial cell function, the role of stem and progenitor cells for endogenous cardiovascular repair as well as their therapeutic application for regenerating cardiovascular function, and the use of biomarkers for risk prediction and therapeutic stratification of patients with acute coronary syndromes.
Prof. Dr. Stefanie Dimmeler (Founder)
Dr. Dimmeler is Professor of Experimental Medicine and Head of the Section of the Institute for Cardiovascular Regeneration at the University of Frankfurt (Germany) since 2001.
Dr. Dimmeler has published more than 150 papers with a global impact factor of higher than 900. She received several of the most prestigious awards including the Award of the German Heart Foundation in 1998, the Frankel-Award of the German Cardiac Society in 2000, the prestigious Alfried Krupp Award 2002 (500.000 €), the Leibniz Award 2005 (1.5 Mio €), the FEBS award 2006 and most recently together with Prof. Zeiher and Prof. Penninger the E. Jung Award. She presented the prestigious George E. Brown Memorial Lecture at the Scientific Sessions of the AHA in 2005 and the Basic Science Lecture of the European Society of Cardiology in 2006. She is on the editorial board of The Journal of Clinical Investigation, Circulation, Circulation Research and others. She is co-founder of the European Network of Excellence “Vascular Genomic Network (EVGN)” supported by the European Community and co-director of the Transatlantic Network of Cardiac Regeneration supported by the Leducq Foundation.
Her research is predominantly focused on endothelial cell biology, including signal transduction, apoptosis, and renewal by circulating endothelial progenitor cells in health and disease. She identified novel signaling pathways mediating the synthesis and release of the endothelial protective factors nitric oxide (NO). Together with Dr. Zeiher, she has been translating science from bench to bedside culminating in current clinical trials of human progenitor cells for cardiovascular repair.